Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Galichon

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Ebiomedicine|June 11, 2018
Epithelial Signaling through the RUNX1/AKT Pathway: A New Therapeutic Target in Kidney FibrosisPierre Galichon
The New England Journal of Medicine|July 29, 2016
Kidney Transplants from HLA-Incompatible Live Donors and SurvivalCharel Linster, Pierre Galichon
Fibrogenesis & Tissue Repair|April 8, 2011
Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside?Pierre Galichon, Alexandre Hertig
Lancet (London, England)|February 16, 2016
A call to improve the submission processPierre Galichon, Aurélien Bataille
Cancer Letters|April 25, 2013
EMT-MET in renal disease: should we curb our enthusiasm?Pierre Galichon, Serge Finianos, Alexandre Hertig
The New England Journal of Medicine|November 8, 2013
Urinary-cell mRNA and acute kidney-transplant rejectionPierre Galichon, Alexandre Hertig, Eric Rondeau
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 30, 2013
Minimal change disease and lenalidomideMatthieu Jamme, Pierre Galichon, Alexandre Hertig
Idcases|February 24, 2022
Peritoneal TuberculosisRuben Azencot, Philippe Rouvier, Pierre Galichon
The New England Journal of Medicine|March 17, 2021
Finerenone and Chronic Kidney Disease Outcomes in Type 2 DiabetesArriel B Makembi, Inna Mohamadou, Pierre Galichon
Hepatology (Baltimore, Md.)|April 12, 2011
Warning: Genome-wide association studies can be misleading. An example in hepatologyPierre Galichon, Alexandre Hertig, Eric Rondeau, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Ebiomedicine|June 11, 2018
Epithelial Signaling through the RUNX1/AKT Pathway: A New Therapeutic Target in Kidney FibrosisPierre Galichon
The New England Journal of Medicine|July 29, 2016
Kidney Transplants from HLA-Incompatible Live Donors and SurvivalCharel Linster, Pierre Galichon
Fibrogenesis & Tissue Repair|April 8, 2011
Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside?Pierre Galichon, Alexandre Hertig
Lancet (London, England)|February 16, 2016
A call to improve the submission processPierre Galichon, Aurélien Bataille
Cancer Letters|April 25, 2013
EMT-MET in renal disease: should we curb our enthusiasm?Pierre Galichon, Serge Finianos, Alexandre Hertig
The New England Journal of Medicine|November 8, 2013
Urinary-cell mRNA and acute kidney-transplant rejectionPierre Galichon, Alexandre Hertig, Eric Rondeau
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 30, 2013
Minimal change disease and lenalidomideMatthieu Jamme, Pierre Galichon, Alexandre Hertig
Idcases|February 24, 2022
Peritoneal TuberculosisRuben Azencot, Philippe Rouvier, Pierre Galichon
The New England Journal of Medicine|March 17, 2021
Finerenone and Chronic Kidney Disease Outcomes in Type 2 DiabetesArriel B Makembi, Inna Mohamadou, Pierre Galichon
Hepatology (Baltimore, Md.)|April 12, 2011
Warning: Genome-wide association studies can be misleading. An example in hepatologyPierre Galichon, Alexandre Hertig, Eric Rondeau, et al.
Pageof 6